(Q46925602)

English

Structurally altered peptides reveal an important role for N-terminal heptad repeat binding and stability in the inhibitory action of HIV-1 peptide DP178.

scientific article published in February 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16455666

Structurally altered peptides reveal an important role for N-terminal heptad repeat binding and stability in the inhibitory action of HIV-1 peptide DP178. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16455666

Robert Blumenthal

4

object named as

Robert Blumenthal

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16455666

author name string

Yael Wexler-Cohen

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16455666

Benitra T Johnson

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16455666

Anu Puri

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16455666

Yechiel Shai

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16455666

language of work or name

0 references

publication date

1 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16455666

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16455666

281

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16455666

14

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16455666

9005-9010

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16455666

HIV entry and its inhibition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

The HIV Env-mediated fusion reaction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Structural basis for membrane fusion by enveloped viruses

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Mechanisms of viral membrane fusion and its inhibition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Capture of an early fusion-active conformation of HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

HIV fusion and its inhibition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Mode of action of an antiviral peptide from HIV-1. Inhibition at a post-lipid mixing stage

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Synthesis of the antibacterial peptide cecropin A (1-33).

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Mode of action of the antibacterial cecropin B2: a spectrofluorometric study.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Analysis of antimicrobial peptide interactions with hybrid bilayer membrane systems using surface plasmon resonance.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Exploring peptide membrane interaction using surface plasmon resonance: differentiation between pore formation versus membrane disruption by lytic peptides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Interpreting complex binding kinetics from optical biosensors: a comparison of analysis by linearization, the integrated rate equation, and numerical integration.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

A monomeric 3(10)-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Interhelical interactions in the gp41 core: implications for activation of HIV-1 membrane fusion

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Interaction of D-amino acid incorporated analogues of pardaxin with membranes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Structural adaptation of the glycophorin A transmembrane homodimer to D-amino acid modifications

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Inhibition of HIV-1 envelope glycoprotein-mediated cell fusion by a DL-amino acid-containing fusion peptide: possible recognition of the fusion complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

A trimeric structural domain of the HIV-1 transmembrane glycoprotein.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512475200

21 January 2018

Identifiers

10.1074/JBC.M512475200

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16455666

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16455666

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46925602&oldid=1817232542"